RXD

Pharmacy/Treatment Dispense

No description available in the specification.
33
C.LenElementv2.4
1..4-NMR1-00334RXD-1Dispense Sub-ID Counter
2..250-CER1029200335RXD-2Dispense/Give CodeData Type
3..26-TSR1-00336RXD-3Date/Time Dispensed
4..20-NMR1-00337RXD-4Actual Dispense Amount
5..250-CEC1-00338RXD-5Actual Dispense Units
6..250-CEO1-00339RXD-6Actual Dosage Form
7..20-STR1-00325RXD-7Prescription Number
8..20-NMC1-00326RXD-8Number of Refills Remaining
9..200-STO*-00340RXD-9Dispense Notes
10..200-XCNO*-00341RXD-10Dispensing Provider
11..1-IDO1016700322RXD-11Substitution Status
12..10-CQO1-00329RXD-12Total Daily Dose
13..200-LA2C1-01303RXD-13Dispense-to LocationName
14..1-IDO1013600307RXD-14Needs Human Review
15..250-CEO*-00330RXD-15Pharmacy/Treatment Supplier's Special Dispensing Instructions
16..20-NMO1-01132RXD-16Actual Strength
17..250-CEO1-01133RXD-17Actual Strength Unit
18..20-STO*-01129RXD-18Substance Lot Number
19..26-TSO*-01130RXD-19Substance Expiration Date
20..250-CEO*022701131RXD-20Substance Manufacturer NameData Type
21..250-CEO*-01123RXD-21Indication
22..20-NMO1-01220RXD-22Dispense Package Size
23..250-CEO1-01221RXD-23Dispense Package Size Unit
24..2-IDO1032101222RXD-24Dispense Package Method
25..250-CEO*-01476RXD-25Supplementary Code
26..250-CEO1-01477RXD-26Initiating Location
27..250-CEO1-01478RXD-27Packaging/Assembly Location
28..5-NMO1-01686RXD-28Actual Drug Strength VolumeNEW
29..250-CWEO1-01687RXD-29Actual Drug Strength Volume UnitsNEW
30..180-CWEO1-01688RXD-30Dispense to PharmacyNEW
31..106-XADO1-01689RXD-31Dispense to Pharmacy AddressNEW
32..1-IDO1048001690RXD-32Pharmacy Order TypeNEW
33..250-CWEO1048401691RXD-33Dispense TypeNEW
7

Editorial Comments for RXD2

TODOField 30

description should match the item name: intended usage is "dispense to"

FO
TODOField 31

description should match the item name: intended usage is "dispense to"

FO